A decreasing trend was observed in the size distribution of the TET1 formulation, where the average particle size was 404.5 ± 9.8 nm on the day of preparation, decreasing to 304 ± 11.87 nm after 3 months ( Table 4 ).
← all excerpts
Transdermal Insulin Delivery Using Ionic Liquid-Mediated Nanovesicles for Diabetes Treatment.
1
—
—